Codexis Reaches New 1-Year High at $2.65 (CDXS)
Codexis (NASDAQ:CDXS) shares reached a new 52-week high during mid-day trading on Tuesday , AnalystRatings.Net reports. The company traded as high as $2.65 and last traded at $2.65, with a volume of 110,547 shares changing hands. The stock had previously closed at $2.47.
The stock has a 50-day moving average of $2. and a 200-day moving average of $1.78. The company’s market cap is $102.5 million.
Codexis (NASDAQ:CDXS) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.22) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.15) by $0.07. The company had revenue of $6.60 million for the quarter, compared to the consensus estimate of $8.50 million. During the same quarter in the prior year, the company posted ($0.33) earnings per share. The company’s quarterly revenue was down 5.7% on a year-over-year basis. On average, analysts predict that Codexis will post $-0.36 earnings per share for the current fiscal year.
In other Codexis news, Director Patrick Y. Yang purchased 60,000 shares of the stock on the open market in a transaction that occurred on Tuesday, August 12th. The shares were purchased at an average cost of $2.22 per share, for a total transaction of $133,200.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Codexis, Inc provides biocatalyst and fermentation processes and products. The Company provides its customers research and development services, biocatalysts and fermentation strains, synthetic and natural products.